Alzamend Neuro Stock (NASDAQ: ALZN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 10.03K |
Day Range | - - - |
52 Wk Range | 3.52 - 81.00 |
Market Cap | $2.92M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 13.1% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alzamend Neuro (NASDAQ:ALZN) through any online brokerage.
Other companies in Alzamend Neuro’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO) and Quoin Pharmaceuticals (NASDAQ:QNRX).
There is no analysis for Alzamend Neuro.
Alzamend Neuro has a consensus price target of $4.75.
The stock price for Alzamend Neuro (NASDAQ: ALZN) is $3.66 last updated July 19, 2024 at 4:44 PM EDT.
There are no upcoming dividends for Alzamend Neuro.
Alzamend Neuro’s Q1 earnings are confirmed for Friday, October 11, 2024.
There is no upcoming split for Alzamend Neuro.
Alzamend Neuro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.